Últimas noticias sobre Virios Therapeutics (NASDAQ:VIRI) Bolsa

Virios Therapeutics

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Virios Therapeutics Inc

VIRIDIAN THERAPEUTICS ORD

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics Inc

Viridien

Viridien ADR

VIRIDIS MINING & MINERALS by VIRIDIS MINING & MINERALS LTD.

Viridis Mining and Minerals Ltd

ETF HITS HIGH OF THE DAY AT 1:59 PM EDT AFTER SIGNAL AT 10:36 AM EDT
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="831" height="800" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/07201500/Screen-Shot-2024-10-07-at-4.15.02-PM.png" alt="" class="wp-image-2078" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/07201500/Screen-Shot-2024-10-07-at-4.15.02-PM.png 831w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/07201500/Screen-Shot-2024-10-07-at-4.15.02-PM-300x289.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/07201500/Screen-Shot-2024-10-07-at-4.15.02-PM-768x739.png 768w" sizes="(max-width: 831px) 100vw, 831px" /></figure>
GraniteShares 2x Long NDVA , (NVDL) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:36 AM on October 7th, a significant trading signal occurred for GraniteShares 2x Long NDVA, (NVDL) as it demonstrated a Power Inflow at a price of $62.93. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Amazon&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Amazon&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separates and studies both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted by active traders as a bullish signal.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for NVDL, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data are brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $62.93. The returns on the High price ($66.71) and Close price ($63.92) after the Power Inflow were respectively 6.0% and 1.6%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case, the high of the day was much higher than the price at the market close.
Past Performance is Not Indicative of Future Results

Signals

Trading Ideas

ETFs

General

Tradepulse Power Inflow Alert: NVDL, Graniteshares 2X Long NVDA Daily ETF Rises 6% After Signal

Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) is having its Robotaxi Day this week. The &lsquo;We, Robot&rsquo; event will be held on October 10th&nbsp;in Hollywood as Tesla booked the massive&nbsp;Warner Bros. Discovery Inc. Studios to unveil its latest model. Considering the impressive venue and the fact&nbsp;that Tesla had delayed this&nbsp;event in order to make some important changes, expectations are high and there are many speculations of what the EV king plans to unveil, the day promises to be &quot;one&nbsp;for the history books&quot;.
Optimizing the charging process.&nbsp;
Yet, the week got kicked off by Nissan Motor Co Ltd (OTC: <a class="ticker" href="https://www.benzinga.com/stock/nsany#OTC">NSANY</a>)&nbsp;deciding to join Bayerische Motoren Werke Aktiengesellschaft (OTC: <a class="ticker" href="https://www.benzinga.com/stock/bmwyy#OTC">BMWYY</a>), Ford Motor (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/f#NYSE">F</a>), and Honda Motor Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmc#NYSE">HMC</a>), or more precisely the trio&rsquo;s EV integration joint venture.&nbsp;Through its investment, Nissan revealed it will become an equal 25% investor&nbsp;in ChargeScape. BMW and Honda had presented ChargeScape&rsquo;s software that optimizes charging. Through ChargeScape, BMW, Honda, Ford and now Nissan, will provide bidirectional charging, allowing EVs to send power back to the grid when needed, while optimizing the charging process by coordinating with real-time grid demands. Also, BMW, Ford, Honda and Nissan will be providing financial incentives to EV owners to reduce energy use during peak times.&nbsp;
Bringing more clean energy to the EV table.
Having already established a reputation for its &lsquo;made-in-the-USA&rsquo; hybrid and clean energy solutions for light trucks, Worksport Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wksp#NASDAQ">WKSP</a>) is preparing for a market release of its solar-powered tonneau cover, SOLIS&nbsp;&nbsp;and the COR portable energy system. This clean energy power duo that promises off-grid power on the go has the potential to propel Worksport&rsquo;s mid to long-term revenues. Worksport already has an ongoing collaboration with Hyundai who secured access to these groundbreaking accessories. Also, Worksport will be releasing one of the most in-demand tonneau cover models, AL4 premium tonneau Cover, in the fourth quarter, with innovative four-fold design that offers enhanced functionality and ease of the use. By launching three new product lines, Worksport is aiming to strengthen its positioning and expand market reach. In the fourth quarter, Worksport will also be implementing cost-saving measures to&nbsp;enhance margins and&nbsp;lower operational overhead&nbsp;without compromising growth. With these key strategic advances that will undoubtedly accelerate revenue growth and boost margings, Worksport is aiming for&nbsp;cash flow positivity un 2025.&nbsp;
While Tesla still holds the EV crown, long gone are the days it had the EV throne to itself. Besides already sharing the crown with BYD Company Limited (OTC: <a class="ticker" href="https://www.benzinga.com/stock/byddy#OTC">BYDDY</a>) on some fronts, both traditional automakers and newcomers are also shaping the EV landscape that is in the making, such as Worksport whose SOLIS and COR off-grid clean power duo promises to revolutionize the pickup experience altogether.&nbsp;
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Penny Stocks

Markets

Tech

BMWYY

BYDDY

NSANY

TSLA

WKSP

The EV Evolution Goes On With New Developments

In a recent conversation with Chris Wallace on CNN Max, <a href="https://www.benzinga.com/personal-finance/24/09/40963028/suze-orman-says-keep-your-car-for-15-years-or-longer-instead-of-leasing-a-new-one-every-3-years-">Suze Orman</a> highlighted that while the stock market is performing well, it doesn't reflect how most American households are really doing financially. 
"What if I were to tell you that 75% of the people in the United States don&#8217;t have $400 to their name in case of an emergency?" Orman said, describing the financial situation of ordinary Americans as &#8220;really, really bad.&#8221;
Don't Miss:
<ul>
<li>How do billionaires pay less in income tax than you? <a href="https://www.benzinga.com/money/tax-deferring-adv" target="_blank" rel="noreferrer noopener">Tax deferring is their number one strategy</a>.</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund" target="_blank" rel="noreferrer noopener"> you can become part of the next big real estate boom today.</a></li>
</ul>
Although we often use the stock market to measure <a href="https://www.benzinga.com/personal-finance/24/06/39565555/suze-orman-breaks-on-the-overall-economy-vs-an-individual-economy-says-on-an-individual-level-i-">economic health overall</a>, Orman emphasizes that it doesn't reliably tell us how the everyday American is doing. &#8220;On the whole, ordinary human beings in America today are living paycheck to paycheck and they&#8217;re not doing well at all," she explained.&nbsp;
As household debts rise and reliance on credit cards increases, it's clear that individuals may be in a deeper financial crisis. Last summer, <a href="https://www.benzinga.com/personal-finance/24/08/40420920/we-have-the-highest-credit-card-debt-in-the-history-of-earth-says-grant-cardone-america-needs-to">U.S. credit card debt</a> surpassed $1 trillion for the first time, a milestone that Orman pointed to as a symptom of a much larger issue.
See Also: <a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved" target="_blank" rel="noreferrer noopener">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a>
Even as some sectors of the economy show strength, Orman made it clear that inflation makes it difficult for most Americans to keep up. Wallace, taken aback by Orman's statistics, asked her to elaborate on what she described as a "financial pandemic."
"We're in a pandemic in that there isn't a financial vaccine to cure this," Orman explained, adding that the crisis won't be resolved by external forces. The only way forward, she argues, is for individuals to take responsibility for their financial well-being. "The government's not gonna save them. The economy is not gonna save them. They&#8217;re gonna have to be their own financial vaccine so to speak."
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Orman's stark warning reflects a growing disconnect between market performance and individual financial health. While stock market gains might boost portfolios for wealthier Americans, many face difficult choices, living paycheck to paycheck with little to no safety net.
A recent MarketWatch survey corroborates Orman, stating that nearly two-thirds of Americans feel like they are living paycheck to paycheck. The report statistics were pulled by nearly 48% of people earning $100,000 or more annually and 36% earning $200,000 or more.
In response to this crisis, Orman has cofounded SecureSave, a business that addresses one critical component of personal finance: <a href="https://www.benzinga.com/personal-finance/24/08/40531988/you-dont-need-emergency-savings-says-grant-cardone-claims-that-three-months-of-savings-in-case-o">emergency savings</a>. Through this business, Orman hopes to help people build a financial cushion that can protect them in times of need.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Beating the market through ethical real estate investing' — <a href="https://www.benzinga.com/money/invest-with-roots">this platform aims to give tenants equity in the homes they live in while scoring 17.17% average annual returns for investors – here&#8217;s how to join with just $100</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
"The goal of money is for you to be secure," Orman told Wallace. She explained that SecureSave partners with employers to allow workers to automatically save a portion of their paycheck, making it easier to build an emergency fund without thinking too much about it.
With the program, employees can save small amounts, such as $25 per paycheck, and some employers offer to match a portion of those contributions. &#8220;Within a year period of time, they have about $1,000,&#8221; Orman noted, adding that the goal isn't to amass large sums right away but rather to establish a savings habit that can lead to bigger habits like saving for retirement.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: The global games market is projected to generate $272B by the end of the year — <a href="https://www.benzinga.com/money/gameflip" target="_blank" rel="noreferrer noopener">for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
These emergency savings accounts are FDIC-insured and employees can access the money whenever needed.&nbsp;
The stock market may be doing well, which is great for retirement and investment accounts, but many people don't have the basics of emergency savings. Orman's message is that security doesn't come from market gains – not that it can't help – but from building healthy financial habits like emergency savings that can provide stability in uncertain times.&nbsp;
If you're facing financial uncertainty and unsure where to start building security with your own finances, consider speaking with a <a href="https://www.benzinga.com/money/best-online-financial-advisors">financial advisor</a>. They will offer advice tailored to your unique situation and help you determine a plan that matches your financial goals. 
Editor&#8217;s note: This story has been updated with additional details. 
Read Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
<li>Amid the ongoing EV revolution, previously overlooked low-income communities <a href="https://www.benzinga.com/money/dunamis-1" target="_blank" rel="noreferrer noopener">now harbor a huge investment opportunity at just $500.</a></li>
</ul>

Personal Finance

Suze Orman Says The Personal Finance Of Americans Is 'Really, Really Bad' Even Though The Stock Market Is Doing Great

Some analysts think the market can't be timed. They think that it follows a &#8220;random walk.&#8221; These analysts are wrong.
Successful traders can identify important price levels. They know when a stock reaches one of them, there is a good chance the trend reverses. That's how they time the market and profit. An example of this can be seen on the chart of Southern Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>). This is why it is our<a href="https://www.benzinga.com/topic/stock-of-the-day"> Stock of the Day.</a>
The $88.50 level has been important for Southern Company since early August. It was resistance then and now it's a support level.
In the stock market, price levels that were once resistance can turn into support levels. It is a common occurrence. There is a reason for this. It isn't &#8220;random,&#8221; it is because of market psychology.
There are traders and investors who thought selling their shares was a good idea when the price traded lower. But some of them thought they made a mistake when the stock broke the resistance and moved higher.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/10/41209505/hurricane-milton-is-floridas-second-storm-in-two-weeks-how-disney-theme-parks-insurance-companie">Hurricane Milton Is Florida&#8217;s Second Storm In Two Weeks: How Disney, Theme Parks, Insurance Companies Could Be Impacted</a>
Many of these remorseful sellers decide to buy their shares back, if they could get them for the same price they sold them at. As a result, when<a href="https://www.benzinga.com/quote/SO"> Southern</a> <a href="https://www.benzinga.com/quote/SO">Company</a> reversed and got back to the level that had been resistance, they placed buy orders.
If there are enough of these buy orders, the level that was resistance can convert into a support level. As you can see on the chart, this was the case with the $88.50 level for Southern Company.
Successful traders know that markets are not random. Market moves are the result of investor and trader psychology. This psychology results in some price levels having more importance than others.
When a stock reaches one of them, savvy traders know there's a good chance the trend reverses. They also know there will be chances for low-risk trading opportunities.
Read Next: • <a href="https://www.benzinga.com/general/entertainment/24/10/41214476/will-kamala-harriss-media-blitz-including-60-minutes-and-call-her-daddy-improve-her-2024-el">Will Kamala Harris&#8217;s Media Blitz, Including &#8217;60 Minutes&#8217; And &#8216;Call Her Daddy,&#8217; Improve Her 2024 Election Prospects?</a>
Photo: Joshua Choate from Pixabay

Technicals

Stock Of The Day: Is Southern Company About To Head North?

The Company has recently undergone a significant transformation, including substantially refreshing its Board and management team, and is focused on continuing to provide industry leading service and executing its strategic plan with a renewed sense of continuous improvement, transparency and accountability.

News

FWRD

Forward Air Says Refreshed Board And Management Team Are Actively Analyzing Business And Strategy To Ensure Company Pursues Best Path Forward To Enhance Shareholder Value

Stronger-than-expected U.S. economic data and surging oil prices are reshaping market expectations for the <a href="https://www.benzinga.com/topic/interest-rates">Federal Reserve&#8217;s November meeting. </a>
Traders, who initially expected an aggressive 50-basis-point rate cut, are now opting on a smaller 25-basis-point move, with odds of a potential pause in the Fed&#8217;s easing cycle surging sharply in recent hours.
Following the 50-basis-point rate cut in September, a hold could be seen as an admission that the Fed may have been significantly wrong about the weakness in the U.S. labor market.
<h1 class="wp-block-heading">A Surprising Economic Upswing</h1>
The U.S. economy continues to defy predictions of a slowdown. 
In September, the U.S. economy added a staggering 254,000 nonfarm payrolls, far exceeding forecasts of 140,000 and the 12-month average of 200,000. The unemployment rate fell unexpectedly to 4.1%, and wage growth accelerated, beating economists' expectations across the board. These factors are making it harder for the Fed to justify additional aggressive cuts in the short term.
Adding fuel to the fire, geopolitical tensions in the Middle East have escalated dramatically. 
The ongoing conflict between Israel and Hezbollah, fueled by Iran&#8217;s missile attacks and the threat of Israeli retaliation, has sent oil prices skyrocketing by over 11% in just five days, with West Texas Intermediate crude breaking through $77 per barrel. 
This surge in energy prices has pushed inflationary pressures higher, pushing traders to contemplate the option of a hold in interest rates.
<h1 class="wp-block-heading">Traders Eye Bets On Fed Holding Rates</h1>
With the economy firing on all cylinders and inflation risks rising, traders have now priced out the probability of a 50-basis-point cut in December, and attention has shifted to whether the Fed will hold rates steady in November.
Market-implied probabilities of a hold have jumped to 14%, up from just 2% on Friday and 0% the previous week, according to the CME FedWatch tool.
<h1 class="wp-block-heading">Market Implied Probabilities For November Federal Reserve Meeting</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td></td>
<td>Oct. 7, 2024</td>
<td>1 Day Ago (Oct 4, 2024)</td>
<td>1 Week ago (Sept. 30 2024)</td>
</tr>
<tr>
<td>50-basis-point cut</td>
<td>0%</td>
<td>0%</td>
<td>34.7%</td>
</tr>
<tr>
<td>25-basis-point cut</td>
<td>86%</td>
<td>97.4%</td>
<td>65.3%</td>
</tr>
<tr>
<td>No rate cut </td>
<td>14%</td>
<td>2.6%</td>
<td>0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Data: CME FedWatch as of Oct. 7, 2024 at 3.00 p.m. ET</figcaption></figure>
This shift in expectations pushed 10-year bond yields back above the 4% mark — hardly what investors usually see in a rate-cut environment. On Monday, the U.S. Treasury 10-Year Note ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTEN#NYSE">UTEN</a>) dropped 0.4%, marking its fourth consecutive negative session.
Bank of America economist Aditya Bhave said, &#8220;The data flow since the Fed&#8217;s 50bp September cut has been remarkably strong. Another 50bp cut isn't warranted.&#8221; He added that the bank now expects the Fed to adopt a more gradual approach, cutting rates by 25 basis points per meeting until March 2025.
&#8220;Right now, a series of more modest 25 basis point cuts would serve to help normalize conditions based on the latest data without getting too aggressive. I'm still concerned that falling rates while the economy is still in good shape runs the risk of another round of inflation,&#8221; said analyst Michael Gayed, CFA.
<h1 class="wp-block-heading">Veteran Investor Outlines 12 Reasons Why The Fed Should Keep Rates On Hold</h1>
Veteran Wall Street investor Ed Yardeni outlined in a post on Monday 12 reasons why the Fed should pause rate cuts in November:
<ol>
<li>The U.S. economy didn't need September's 50bps cut, as proven by the latest employment and PMI data.</li>
<li>Fed officials may regret cutting by 50bps in September and should now hold steady to evaluate further data.</li>
<li>Rising bond yields since the September cut suggest the easing wasn't necessary and could fuel stronger growth.</li>
<li>Further cuts could trigger a stock market &#8220;meltup,&#8221; as valuations are already nearing 1990s levels.</li>
<li>Geopolitical risks in the Middle East have pushed oil prices higher, raising stagflation concerns reminiscent of the 1970s.</li>
<li>Hurricane Helene&#8217;s aftermath could stimulate inflationary pressures due to rebuilding efforts.</li>
<li>The recent dockworkers' pay settlement may increase import costs and fuel wage inflation.</li>
<li>Both U.S. presidential candidates propose fiscal programs that could widen the federal deficit and be inflationary.</li>
<li>China's economic stimulus is driving up global commodity prices, adding to inflationary risks.</li>
<li>Further rate cuts could weaken the dollar, potentially exacerbating inflation.</li>
<li>Core inflation remains above the Fed's 2% target, with "supercore" inflation stuck above 3%.</li>
<li>The real neutral Fed Funds rate could be higher than the Fed estimates, suggesting a nominal neutral rate closer to 4.0%.</li>
</ol>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/10/41213691/fast-and-furious-rally-pushes-chinese-stocks-to-double-s-p-500-performance-year-to-date">&#8216;Fast And Furious Rally&#8217; Pushes Chinese Stocks To Double S&amp;P 500 Performance Year To Date</a></li>
</ul>
The image was created using artificial intelligence.

Analyst Color

Macro Economic Events

Bonds

Specialty ETFs

Econ #s

Economics

Federal Reserve

Analyst Ratings

UTEN

November Fed Rate Cut In Jeopardy: 12 Reasons Veteran Trader Expects A Hold As Strong Data, Rising Oil Prices Shuffle The Deck

The Company promptly took steps to shut down the unauthorized access, notified the third party its systems had been compromised, launched an investigation, and implemented counter measures intended to safeguard the Company&rsquo;s information technology assets and operations.
ADT has hired leading third-party cybersecurity experts to assist with the Company&rsquo;s response to the incident, and is working closely with federal law enforcement. The Company is also cooperating closely with its third-party business partner to address the incident.
The Company believes the unauthorized actor exfiltrated certain encrypted internal ADT data associated with employee user accounts during the intrusion.

ADT Says Recently Became Aware Of Unauthorized Activity On Its Network; Says It Does Not Believe Customers' Personal Information Has Been Exfiltrated - Filing

Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) has outperformed the market over the past 10 years by 14.24% on an annualized basis producing an average annual return of 25.94%. Currently, Quanta Services has a market capitalization of $45.31 billion. 
Buying $1000 In PWR: If an investor had bought $1000 of PWR stock 10 years ago, it would be worth $9,840.32 today based on a price of $307.51 for PWR at the time of writing.
<h3>Quanta Services's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728336618_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth $9,800 Today

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) has outperformed the market over the past 10 years by 6.66% on an annualized basis producing an average annual return of 18.36%. Currently, Salesforce has a market capitalization of $272.05 billion. 
Buying $1000 In CRM: If an investor had bought $1000 of CRM stock 10 years ago, it would be worth $5,346.05 today based on a price of $284.57 for CRM at the time of writing.
<h3>Salesforce's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728336613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Salesforce 10 Years Ago Would Be Worth Today

ESRT

Empire State Realty Trust Reveals Four New Tenants To Its Retail Portfolio And Plans To Open New Ticketing Center At The Empire State Building Observatory

Guidance

Associated Capital Reports Preliminary Range For Q3 Book Value Of $41.85 To $42.05 Per Share

Rosenblatt analyst Blair Abernethy maintains Cadence Design Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) with a Neutral and maintains $280 price target.

Price Target

CDNS

Rosenblatt Maintains Neutral on Cadence Design Sys, Maintains $280 Price Target

Hemp companies in <a href="https://www.benzinga.com/topic/new-jersey-cannabis">New Jersey</a> have filed a lawsuit challenging the <a href="https://www.benzinga.com/markets/cannabis/24/09/40845389/nj-governor-signs-bill-tightening-rules-on-hemp-industry-stakeholders-protest-big-alcohol-celebr">newly signed regulation</a> that limits the sale of hemp derived products like Delta-8 THC.
Arguing that the new regulations effectively criminalize hemp, the plaintiffs say hemp is federally legal under the<a href="https://www.benzinga.com/markets/cannabis/24/07/39783607/how-hemp-became-americas-loophole-for-legal-highs"> 2018 Farm Bill</a>, and that New Jersey&#8217;s regulations will force many of them out of business.
In the lawsuit, they also argue that vague terms in the law make compliance difficult. They are seeking a federal court's intervention before the October 12 deadline, when all hemp products must be pulled from shelves.
<h3 class="wp-block-heading">New Jersey's Defense Of The Law</h3>
In response, New Jersey's state attorneys have filed a motion to dismiss the lawsuit, defending the law as a necessary public health measure, <a href="https://newjerseymonitor.com/2024/10/04/state-urges-judge-to-reject-lawsuit-about-new-hemp-regulations/#:~:text=New%20Jersey%20is%20arguing%20that,aimed%20at%20blocking%20the%20law.">reported</a> New Jersey Monitor. 
The argument by the government says that the&nbsp;2018 Farm Bill&nbsp;allows for state-level regulations that aim to address the risks posed by&nbsp;psychoactive hemp products. 
The state's filing emphasized concerns over the health and safety of minors, citing data that shows 11% of high school seniors had used Delta-8 THC in 2023.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40845389/nj-governor-signs-bill-tightening-rules-on-hemp-industry-stakeholders-protest-big-alcohol-celebr">NJ Governor Signs Bill Tightening Rules On Hemp: Industry Stakeholders Protest, Big Alcohol Celebrates</a>
<h3 class="wp-block-heading">New Hemp Law's Restrictions And Impact</h3>
In a written statement, Governor Phil Murphy acknowledged the <a href="https://www.benzinga.com/markets/cannabis/24/09/40845389/nj-governor-signs-bill-tightening-rules-on-hemp-industry-stakeholders-protest-big-alcohol-celebr">law's vagueness</a> but said public safety concerns were paramount.
Signed into law by Murphy, the new hemp regulation bans the sale of intoxicating hemp products. This is unless the seller holds a cannabis or alcohol license.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Overseen by the New Jersey Cannabis Regulatory Commission (CRC), the law aims to curb access to products like THC-infused beverages and Delta-8 THC. However, it also benefits the alcohol industry.
Similar arguments regarding adverse effects on minor have been waved in other states to prevent hemp-derived products from circulating.
In <a href="https://www.benzinga.com/markets/cannabis/24/09/40945349/cannabis-companies-have-missouris-governor-beat-hemp-thc-products-sales-resume-as-stricter-contr">Missouri</a>, Maryland and <a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">California</a>, similar regulations as those imposed sin New Jersey have faced or are currently facing legal disputes. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40346190/75-for-an-eighth-of-an-ounce-why-are-new-jersey-cannabis-prices-still-so-high">How This Former DEA Consultant Is Making Craft Cannabis Profitable In New Jersey: A &#8216;Dirt-y&#8217; Little Secret</a></li>
</ul>
Cover: Photo by Gerome Dominici via Pexels

Cannabis

Government

Regulations

Legal

New Jersey Hemp Companies File Lawsuit Over Strict Regulations, Arguing Farm Bill Protects Them

CHUY

MDU Resources To Replace Chuy's Holdings In S&P SmallCap 600, Effective Prior To Opening Of Trading On October 11

DOCU

DocuSign To Replace MDU Resources In S&P MidCap 400, Effective Prior To Opening Of Trading On October 11

Jones Trading analyst Matthew Erdner initiates coverage on ACRES Commercial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACR#NYSE">ACR</a>) with a Hold rating.

Initiation

Jones Trading Initiates Coverage On ACRES Commercial Realty with Hold Rating

Canaccord Genuity analyst Susan Anderson maintains Helen Of Troy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HELE#NASDAQ">HELE</a>) with a Buy and maintains $84 price target.

HELE

Canaccord Genuity Maintains Buy on Helen Of Troy, Maintains $84 Price Target

Rubicon Organics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RBTCW#OTC">RBTCW</a>) has released its 2023&nbsp;Environmental, Social and Governance (ESG) Report, which demonstrates significant progress by the company in reducing its environmental footprint.
The cannabis company, known for its organic certified products, is one of the few in the industry to publish a comprehensive sustainability report, reflecting the growing importance of&nbsp;<a href="https://www.benzinga.com/topic/climate-change">climate action</a>&nbsp;across sectors.
<h3 class="wp-block-heading">Carbon Footprint Slashed By 48%</h3>
The 2023 ESG Report showcases <a href="https://www.benzinga.com/markets/cannabis/24/08/40397166/rubicons-revenue-grows-profit-margins-shrink-in-q2-whats-next-for-this-canadian-cannabis-company">Rubicon's</a> success in cutting its&nbsp;carbon emissions by 48%, down to&nbsp;2,064 tons. This reduction is largely attributed to a major energy shift through a&nbsp;BC Hydro site upgrade, enabling Rubicon to use cleaner, renewable energy sources.
"We believe we are establishing industry benchmarks and building a robust and resilient cannabis industry in Canada," said Rubicon's CEO Margaret Brodie.
The report also highlights improvements in waste management, with a&nbsp;66% landfill waste diversion rate&nbsp;achieved through recycling, composting, and biofuel repurposing initiatives. These activities also helped reduce the cannabis carbon footprint generated during 2023.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39992555/cannabis-sustainability-why-it-matters-and-how-to-achieve-it-with-practical-inexpensive-measures">Cannabis Sustainability: Why It Matters and How to Achieve It With Practical Inexpensive Measures</a>
<h3 class="wp-block-heading">Cannabis Footprint And ESG Reports </h3>
Although infrequent, reporting <a href="https://www.benzinga.com/topic/sustainability">sustainability</a> achievements like Rubicon's is becoming more common. As industries face mounting pressure to address&nbsp;climate change&nbsp;and corporate responsibility, the trend is for customers to value the efforts made by companies to diminish the environmental impacts of their activity.
While still relatively rare in the cannabis sector, the trend is gaining momentum globally.
Insights from the <a href="https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00090-0">scientific paper</a> "A Narrative Review on Environmental Impacts of Cannabis Cultivation" by environmentalists Zhonghua Zheng, Kelsey Fiddes and Liangcheng Yang help frame Rubicon's progress. The review noted that cannabis cultivation is notoriously <a href="https://www.benzinga.com/general/biotech/23/04/31620821/the-environmental-impact-of-cannabis-sustainable-growth-or-eco-disaster">resource-intensive</a>, with significant water use and greenhouse gas emissions tied to indoor growing operations.
Related to this, Rubicon's reductions in natural gas usage are vital to the mitigation of the environmental impact of indoor cannabis production.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Diversity-Minded Company</h3>
Beyond carbon reduction, Rubicon had a 6% increase in employee count, ending 2023 with 178 workers. The company hired 65 new employees.
For the second year in a row, Rubicon reduced its&nbsp;employee turnover, down to&nbsp;32%&nbsp;from 43% in 2022. The company maintained its focus on diversity, with&nbsp;83%&nbsp;of the workforce belonging to underrepresented groups.
On the equity front, the&nbsp;gender wage gap&nbsp;favored women, with female employees earning&nbsp;33% more than men, while the company&#8217;s&nbsp;CEO pay ratio&nbsp;decreased to&nbsp;14.4:1&nbsp;from&nbsp;28.5:1&nbsp;in 2022.
If you&#8217;re curious about the report, which is the 4th put out by the company, you can download it <a href="https://www.rubiconorganics.com/our-business/esg-reporting/">here</a>.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40496120/new-york-cannabis-growers-given-one-year-to-submit-mandatory-sustainability-plans">New York Cannabis Growers Given One Year To Submit Mandatory Sustainability Plans</a></li>
</ul>
Cover: AI generated image

RBTCW

Rubicon Organics: 83% Of Workforce From Diverse Groups, Women Earn 33% More Than Men, Cuts Carbon Footprint By 48% YoY

Beverage and food giant PepsiCo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) could provide an insight on shoppers' habits in the face of rising costs at the grocery store when third-quarter financial results are reported Tuesday <a href="https://www.benzinga.com/earnings">before market open</a>.
Earnings Estimates: Analysts expect PepsiCo to report third-quarter revenue of $23.83 billion, up from $22.32 billion in last year's third quarter, according to data <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100724&amp;t=be2bearmibe3na1">from Benzinga Pro</a>.
The company has beaten analyst estimates for revenue in eight of the last 10 quarters, but missed estimates in two of the last three quarters.
Analysts expect the company to report third-quarter earnings per share of $2.29, up from last year's $2.25. The company has beaten analyst estimates for earnings per share in more than 10 straight quarters.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/24/10/41208875/pepsico-slumps-ahead-of-q3-can-earnings-bring-the-fizz-back">PepsiCo Slumps Ahead Of Q3: Can Earnings Bring The Fizz Back?</a>
Key Items to Watch: Ahead of PepsiCo's third-quarter financial results, several analysts have updated their price targets. Here are<a href="https://www.benzinga.com/quote/PEP/analyst-ratings"> recent analyst ratings </a>on PepsiCo and their respective price targets:
<ul>
<li>RBC Capital: Maintained Sector Perform rating, lowered price target from $177 to $176</li>
<li>Barclays: Maintained Overweight rating, lowered price target from $187 to $186</li>
<li>JPMorgan: Maintained Neutral rating, raised price target from $182 to $185</li>
<li>Bank of America: Maintained Buy rating, lowered price target from $190 to $185</li>
</ul>
PepsiCo's report could provide a gauge of consumer spending, with a strong market share for both beverages and snack foods.
The company said it faced a difficult performance for North America convenient foods in the <a href="https://www.benzinga.com/news/earnings/24/07/39725480/pepsicos-q2-performance-annual-outlook-underwhelms-investors-stock-slides">second quarter</a>, which will likely be closely monitored.
Pepsi also recently announced the acquisition of tortilla chip maker Siete Foods <a href="https://www.benzinga.com/markets/equities/24/10/41118083/pepsico-eyes-tortilla-maker-siete-foods-in-1b-deal-report">for $1.2 billion.</a> The acquisition could bolster Pepsi&#8217;s presence in the healthier snack market and may prompt analysts to question whether further acquisitions are on the horizon.
The beverage and food giant could also update guidance for the full year and share how the Siete acquisition could impact revenue and earnings in the future.
PEP Price Action: PepsiCo stock is down 0.6% to $166.93 on Monday, versus a 52-week trading range of $157.43 to $183.79. Pepsi stock is down 3.4% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41205686/how-to-earn-500-a-month-from-pepsico-stock-ahead-of-q3-earnings">How To Earn $500 A Month From PepsiCo Stock Ahead Of Q3 Earnings</a></li>
</ul>
Photo via Shutterstock.

Previews

Pepsi Q3 Earnings Preview: Can The Beverage Giant Keep Beating Expectations and Boost Revenue Growth?

Tigress Financial analyst Ivan Feinseth maintains Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) with a Buy and raises the price target from $25 to $28.

Tigress Financial Maintains Buy on Carnival, Raises Price Target to $28

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) stock is falling on Monday after the development-stage biotechnology company announced the <a href="https://www.nasdaq.com/press-release/virios-therapeutics-announces-pricing-of-%241.7-million-public-offering-of-common-stock">pricing of a public offering</a> for its shares.



Virios Therapeutics is selling 8.5 million shares of VIRI stock at a price of 20 cents per share. This has the company expecting gross proceeds of $1.7 million from this public offering.



Virios Therapeutics intends to use the funds from this offering for its IMC-2 Long-COVID Phase 2b study. The money will also be used for general corporate purposes. Investors will also note that the sole placement agent for the offering is Maxim Group LLC.



<h2>What This Means for VIRI Stock</h2>



A public stock offering increases the total number of VIRI shares on the market. Doing this dilutes the stakes of current shareholders in the company. That&rsquo;s one reason why VIRI stock is down today.



The other has to do with the pricing of the offering. At 20 cents per share, this is a significant discount from its prior closing price of 35 cents. That&rsquo;s another negative dragging down the price of the stock this morning.



VIRI stock is down 43.8% as of Monday morning. The stock was also down 39.4% year-to-date when markets last closed.



Investors seeking out more of the latest stock market stories are in luck!



We have all of the hottest stock market news ready to go on Monday! A few examples include what&rsquo;s happening with shares of GT Biopharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>)&nbsp;stock, MultiMetaVerse&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock and the biggest pre-market stock movers this morning. That news is good to go at the links below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-gt-biopharma-gtbp-stock-up-143-today/">Why Is GT Biopharma (GTBP) Stock Up 143% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-multimetaverse-mmv-stock-up-105-today/">Why Is MultiMetaVerse (MMV) Stock Up 105% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-20th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Jaguar Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) stock is falling on Monday as the company prepares for a <a href="https://www.nasdaq.com/press-release/jaguar-health-inc.-announces-reverse-stock-split-2024-05-17">reverse stock split later this week</a>.



Jaguar Health is going to enact a one-for-60 reverse stock split on Thursday. That will see it consolidate 60 shares of JAGX stock into a single share. This will have the shares start trading on a split-adjusted basis when markets open that day.



Jaguar Health notes that its shares will continue to trade on the Nasdaq Capital Market under the JAGX ticker post-split. However, the shares will be using 47010C805 as the new CUSIP number after the split.



<h2>What&rsquo;s Behind the JAGX Reverse Stock Split?</h2>



Jaguar Health is undergoing a reverse stock split to boost the price of its shares. The company is doing this to regain compliance with the minimum bid price rule for the exchange.



Jaguar Health also notes that it expects extra benefits from this reverse stock split. It believes it will alter the share price and total outstanding shares in a way that will make the company more attractive to institutional investors.



JAGX stock is down 40.3% as of Monday morning.



There are plenty more stock market stories that traders will want to read about on today. That includes everything happening with shares of Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>), GT Biopharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gtbp-stock-quote/">GTBP</a>) and MultiMetaVerse&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) stock today. All of this news is available below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-gt-biopharma-gtbp-stock-up-143-today/">Why Is GT Biopharma (GTBP) Stock Up 143% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-multimetaverse-mmv-stock-up-105-today/">Why Is MultiMetaVerse (MMV) Stock Up 105% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-jaguar-health-jagx-stock-down-40-today/">Why Is Jaguar Health (JAGX) Stock Down 40% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Jaguar Health (JAGX) Stock Down 40% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Red Lobster bankruptcy is a hot topic among traders on Monday after the popular seafood chain submitted a voluntary filing this morning.



Red Lobster has announced that it will <a href="https://www.prnewswire.com/news-releases/red-lobster-files-voluntary-chapter-11-petitions-to-strengthen-financial-position-and-maximize-value-for-stakeholders-302149769.html">enter Chapter 11 bankruptcy protection</a> as it works to reduce operating expenses. The company is also looking to reduce its number of locations and pursue a sale of all of its assets as a going concern.



Red Lobster intends to keep its restaurants open throughout the bankruptcy. The company notes that it has already obtained a $100 million&nbsp;debtor-in-possession financing agreement from existing lenders to allow this.



Red Lobster CEO Jonathan Tibus said the following about the bankruptcy.




&ldquo;This restructuring is the best path forward for Red Lobster. It allows us to address several financial and operational challenges and emerge stronger and re-focused on our growth. The support we&rsquo;ve received from our lenders and vendors will help ensure that we can complete the sale process quickly and efficiently while remaining focused on our employees and guests.&rdquo;




<h2>Red Lobster Bankruptcy: Locations Closing</h2>



Red Lobster <a href="https://investorplace.com/2024/05/red-lobster-closures-2024-is-your-favorite-restaurant-closing/">closures started last week</a> ahead of the company&rsquo;s bankruptcy filing. That saw the company shutter dozens of stores across the U.S. The company started this while searching for a buyer. It&rsquo;s also been dealing with increased inflation changing consumer habits, higher lease prices as well as increasing labor wages.



Investors will find more of the most recent stock market stories below!



We have all of the latest market happenings worth reading about on Monday! Among that is what has shares of Nvidia&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>), Jaguar Health&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/jagx-stock-quote/">JAGX</a>) and Virios Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) stock moving today. All of that news is available below!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/nvidia-earnings-forecast-what-nvda-stock-investors-can-expect-on-may-22/">Nvidia Earnings Forecast: What NVDA Stock Investors Can Expect on May 22</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-jaguar-health-jagx-stock-down-40-today/">Why Is Jaguar Health (JAGX) Stock Down 40% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-virios-therapeutics-viri-stock-down-44-today/">Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/red-lobster-bankruptcy-what-happened-to-the-popular-seafood-chain/">Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?

Analyst Jason McCarthy of Maxim Group reiterated a Buy rating on Virios Therapeutics (VIRI – Research Report), retaining the price target of $1.00....

Optimistic Buy Rating for Virios Therapeutics as IMC-2 Advances in Clinical Trials with Promising Phase 2 Results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Virios Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/viri-stock-quote/">VIRI</a>) just reported results for the second quarter of 2024.<ul><li>Virios Therapeutics reported earnings per share of -5 cents. This was above the analyst estimate for EPS of -6 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/viri-stock-earnings-virios-therapeutics-for-q2-of-2024/">VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VIRI Stock Earnings: Virios Therapeutics Beats EPS for Q2 2024

Analyst Sean Lee CFA from H.C. Wainwright maintained a Hold rating on Virios Therapeutics (VIRI – Research Report) and decreased the price target t...

Hold Rating Maintained for Virios Therapeutics Amidst Financial Uncertainty and Pipeline Prospects

Virios Therapeutics reports Q2 results

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Virios Therapeutics (VIRI – Research Report), with a pri...

Buy Rating for Virios Therapeutics Amid Promising Long COVID Treatment and Legislative Tailwinds

Virios, and Wex Pharmaceuticals report business combination to form Dogwood Therapeutics

Virios Therapeutics ( ($VIRI) ) has issued an update. Virios Therapeutics, Inc. has merged with Sealbond Limited's subsidiary, Pharmagesic, renamin...

Virios Therapeutics Transforms into Dogwood Therapeutics

GTBP

JAGX

NVDA

VIRI

Earnings

Health Care

Press Releases

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

Financing

Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

IPOs

Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

Comments

Virios Therapeutics

Noticias

Últimas noticias sobre Virios Therapeutics (NASDAQ:VIRI) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL